amlodipine + telmisartan + amiloride compound + simvastatin

This is a combination drug containing four active pharmaceutical ingredients: - **Amlodipine** (a dihydropyridine calcium channel blocker) lowers blood pressure by relaxing vascular smooth muscle, leading to vasodilation. - **Telmisartan** (an angiotensin II receptor blocker, ARB) blocks the action of angiotensin II at the AT1 receptor, preventing vasoconstriction and reducing aldosterone-mediated volume expansion. - **Amiloride compound** (a potassium-sparing diuretic) inhibits sodium reabsorption in the distal convoluted tubules and collecting ducts of the nephron, promoting natriuresis while conserving potassium. - **Simvastatin** (an HMG-CoA reductase inhibitor/statin) reduces cholesterol synthesis in the liver by inhibiting HMG-CoA reductase, thereby lowering LDL cholesterol. The combination targets hypertension through complementary mechanisms—vasodilation, inhibition of renin-angiotensin system activity, and diuresis—while also addressing dyslipidemia via statin therapy. This multi-drug approach may be considered for patients with coexisting hypertension and hypercholesterolemia who require multiple agents for optimal risk reduction. There is no evidence that this specific four-drug combination is available as a single branded or generic product; it appears to be a theoretical or compounded regimen rather than an approved fixed-dose combination.